Our History

Cutting Edge of Robotics Since 1988


Barrett spun out of the Massachusetts Institute of Technology (MIT) Artificial Intelligence Laboratory (now CSAIL) where Barrett’s founder, Bill Townsend, created the world’s first human-interactive robotic arm, funded by NASA, while earning his PhD. With seed investment from Julianne Barrett and grants from NASA, NSF, NIH, DOE, and DARPA, Barrett developed its groundbreaking Puck® motor technology and innovative gearless drives that power its world-class robots, including the WAM® arm, BarrettHand™, and Burt®.

Indeed the Puck® is now used by hundreds of customers worldwide across an array of applications from humanoids, to medical devices, to consumer products that leverage its advantages, including:

  • ultra-compactness (10x smaller than the next smallest)

  • high-performance

  • excellent power-efficiency

  • durability

  • robust control

  • low electrical noise

  • smooth torque control

  • application simplicity (eliminated wires/connectors)

  • auto-tuning for application to any brushless motor

Our robotic therapy solutions have been in the making since 2007. We have introduced innovative robotic technology throughout the years and are incredibly proud of the advancements we have contributed to the medical community. The launch of Burt® in 2019 is a significant achievement in promoting upper-limb recovery from neurological injuries such as stroke, traumatic brain injury (TBI), spinal cord injury (SBI), Parkinson's, and others.

 
Barrett founder Bill Townsend inspecting a WAM Arm in 1997

Barrett founder Bill Townsend inspecting a WAM Arm in 1997


 
MAKO Surgical licenses Barrett’s WAM® in 1998

MAKO Surgical licenses Barrett’s WAM® in 1998


 
In 1999 Barrett licenses key patent for PhanTom®, the first ever haptic device.

In 1999 Barrett licenses key patent for PhanTom®, the first ever haptic device.


 
In 2004 Barrett collaborates with the Rehabilitation Institute of Chicago

In 2004 Barrett collaborates with the Rehabilitation Institute of Chicago


 
In 2010 Barrett exceeds $40m in worldwide sales of robots.

In 2010 Barrett exceeds $40m in worldwide sales of robots.


 
In 2016 Barrett begins a collaboration with Spaulding Rehabilitation Hospital.

In 2016 Barrett begins a collaboration with Spaulding Rehabilitation Hospital.


 

In 2019 Barrett begins its first hospital deployments of Burt®.


 
In 2020 Barrett begins hospital deployments in China through a joint venture with Estun Automation.

In 2021 Barrett begins hospital deployments in China through a joint venture with Estun Automation.

  • Barrett

    Starting out as an MIT spinoff, Barrett introduces the first-ever human-interactive robot.

  • WAM®

    MAKO Surgical licenses Barrett’s flagship WAM® robot arm for their RIO® surgical robot. (MAKO later purchased by Stryker for $1.6B.)

  • PhanTom®

    Barrett licenses key patent to SensAble Technologies for its PhanTom®, the first ever haptic device, a concept that inspired many human-interactive robots like Intuitive Surgical’s DaVinci surgical robot.

  • WAM® most advanced robot

    The special Millennium Edition of the Guinness Book of Records cites the WAM® arm as the world’s “most advanced” robot.

  • WAM® modified

    Barrett collaborates with the Rehabilitation Institute of Chicago, supported by funding from the National Institutes of Health, to modify a WAM® Arm for error-augmentation neurorehabilitation.

  • $40m in robotic sales

    Barrett exceeds $40m in worldwide sales of robots.

  • Burt®

    Barrett kicks off development of Burt®, its neurorehabilitation platform robot.

  • Lower-extremity robot

    Barrett collaborates with Northeastern to create a lower-extremity robot.

  • Spaulding collaboration

    Barrett begins collaboration with Spaulding Rehabilitation Hospital.

  • Burt® Product Launch in the United States

    Barrett begins its first hospital deployments of Burt®.

  • Burt® Product Launch in China

    Barrett begins hospital deployments in China through a joint venture with Estun Automation.